Insider · CIK 0001524849
Robert L Dixon JR
Files at ELV (Elevance Health, Inc.), OKTA (Okta, Inc.). First filing Jun 12, 2026, latest Jun 12, 2026.
In brief
Robert L Dixon JR files SEC Form 4 as director at ELV (Elevance Health, Inc.), and also at OKTA (Okta, Inc.). Since Jun 12, 2026, Robert L Dixon JR has reported 0 open-market buys worth $0 and 1 open-market sell worth $61k, the latest filed on Jun 12, 2026.
A track record needs three past buys with six months of prices behind them; Robert L Dixon JR has 0, so none is measured yet.
The newest scored trade: sold $61k of ELV on Jun 11, 2026, filed Jun 12, 2026, scored 30 (weak). In the last 12 months: 0 buys worth $0 and 1 sell worth $61k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ELV: Elevance Health, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 30Weak | Elevance Health, Inc. | $61k 151 shares | -1% | +48% from low-6% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Jun 11, 2026 | ELV Elevance Health, Inc. | 151 0.00% of outstanding | $61k | Jun 11, 2026 | none |
Transactions
Every row this insider has filed, 8 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 17, 2026 | OKTA Okta, Inc. | MOption exercise Class A Common Stock | +2,487 | $0.00 | $0 | 13,956 | Jun 22, 2026 |
| Jun 17, 2026 | OKTA Okta, Inc. | MOption exercise Restricted Stock Unitsderivative | -2,487 | $0.00 | $0 | 0 | Jun 22, 2026 |
| Jun 11, 2026 | ELV Elevance Health, Inc. | SOpen-market sale Common Stock | -151 | $401.77 | $61k | 10,734 | Jun 12, 2026 |
| May 13, 2026 | ELV Elevance Health, Inc. | AGrant or award Common Stock | +563 | $0.00 | $0 | 10,885 | May 15, 2026 |
| Jun 20, 2025 | OKTA Okta, Inc. | MOption exercise Class A Common Stock | +2,832 | $0.00 | $0 | 11,469 | Jun 24, 2025 |
| Jun 20, 2025 | OKTA Okta, Inc. | MOption exercise Restricted Stock Unitsderivative | -2,832 | $0.00 | $0 | 0 | Jun 24, 2025 |
| Jun 24, 2025 | OKTA Okta, Inc. | AGrant or award Restricted Stock Unitsderivative | +2,487 | $0.00 | $0 | 2,487 | Jun 24, 2025 |
| May 14, 2025 | ELV Elevance Health, Inc. | AGrant or award Common Stock | +601 | $0.00 | $0 | 10,322 | May 16, 2025 |
Questions about Robert L Dixon JR
Answered from the filings on this page, as of the latest one.
Is Robert L Dixon JR buying or selling?
In the last 12 months Robert L Dixon JR reported 0 open-market buys worth $0 and 1 open-market sell worth $61k on SEC Form 4; the latest was sold $61k of ELV on Jun 11, 2026. Grants, option exercises and tax withholding are not counted.
How did Robert L Dixon JR's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Robert L Dixon JR has 0.
Where does Robert L Dixon JR file Form 4?
Robert L Dixon JR has filed Form 4 at ELV (Elevance Health, Inc.); OKTA (Okta, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.